NIP
Nicholas Investment Partners Portfolio holdings
AUM
$1.12B
This Quarter Return
+8.24%
1 Year Return
+50.66%
3 Year Return
+286.38%
5 Year Return
+525.06%
10 Year Return
+2,262.45%
AUM
$1.6B
AUM Growth
+$1.6B
(+0.04%)
Cap. Flow
-$2.13M
Cap. Flow
% of AUM
-0.13%
Top 10 Holdings %
Top 10 Hldgs %
13.02%
Holding
398
New
92
Increased
83
Reduced
71
Closed
78
Top Buys
| 1 |
ACT.PRA
ACTAVIS PLC PFD CONV SER A (IRL)
ACT.PRA
|
$13.6M |
| 2 |
CST
CST Brands, Inc.
CST
|
$10.5M |
| 3 |
Veeva Systems
VEEV
|
$9.49M |
| 4 |
Verint Systems
VRNT
|
$9.14M |
| 5 |
Royal Caribbean
RCL
|
$8.19M |
Top Sells
| 1 |
Las Vegas Sands
LVS
|
$27.5M |
| 2 |
RFMD
RF MICRO DEVICES INC
RFMD
|
$20M |
| 3 |
HDS
HD Supply Holdings, Inc.
HDS
|
$12.4M |
| 4 |
Macy's
M
|
$7.93M |
| 5 |
iShares Russell 2000 Growth ETF
IWO
|
$7.8M |
Sector Composition
| 1 | Consumer Discretionary | 14.78% |
| 2 | Technology | 12.06% |
| 3 | Healthcare | 11.32% |
| 4 | Financials | 7.88% |
| 5 | Industrials | 6.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Charles Schwab
SCHW
$174B
| $1.75M | 0.11% | +57,332 | New | +$1.75M |
|
|
ABMD
227
DELISTED
Abiomed Inc
ABMD
| $1.7M | 0.11% | +23,779 | New | +$1.7M |
|
228
Goldman Sachs
GS
$226B
| $1.7M | 0.11% | 9,021 +822 | +10% | +$155K |
|
229
Visteon
VC
$3.38B
| $1.69M | 0.11% | +17,562 | New | +$1.69M |
|
230
Ford
F
$46.8B
| $1.64M | 0.1% | +101,591 | New | +$1.64M |
|
231
Nike
NKE
$114B
| $1.62M | 0.1% | 16,153 | – | – |
|
|
ALDR
232
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $1.61M | 0.1% | 55,763 +6,325 | +13% | +$183K |
|
|
TWOU
233
DELISTED
2U, Inc.
TWOU
| $1.43M | 0.09% | 56,049 -123,066 | -69% | -$3.15M |
|
|
TIF
234
DELISTED
Tiffany & Co.
TIF
| $1.31M | 0.08% | 14,826 -47,333 | -76% | -$4.17M |
|
|
ONCE
235
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $1.29M | 0.08% | +16,684 | New | +$1.29M |
|
236
Wells Fargo
WFC
$263B
| $1.25M | 0.08% | +22,991 | New | +$1.25M |
|
237
Universal Display
OLED
$6.59B
| $1.21M | 0.08% | 25,795 -19,159 | -43% | -$896K |
|
238
Salarius Pharmaceuticals
SLRX
$2.94M
| $1.2M | 0.08% | +61,377 | New | +$1.2M |
|
239
Insmed
INSM
$28.8B
| $1.19M | 0.07% | +57,124 | New | +$1.19M |
|
|
STRR
240
DELISTED
Star Equity Holdings
STRR
| $1.14M | 0.07% | 250,000 | – | – |
|
|
CPHD
241
DELISTED
Cepheid Inc
CPHD
| $1.13M | 0.07% | 19,776 -116,909 | -86% | -$6.65M |
|
242
NeoGenomics
NEO
$1.13B
| $1.03M | 0.06% | 220,961 +51,485 | +30% | +$240K |
|
|
LOXO
243
DELISTED
Loxo Oncology, Inc
LOXO
| $1.03M | 0.06% | 82,737 +22,232 | +37% | +$277K |
|
|
UTIW
244
DELISTED
UTI WORLDWIDE INC
UTIW
| $999K | 0.06% | +81,254 | New | +$999K |
|
|
EVFM
245
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $969K | 0.06% | 118,012 -2,203 | -2% | -$18.1K |
|
246
Salesforce
CRM
$245B
| $916K | 0.06% | +13,706 | New | +$916K |
|
|
TWC
247
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $808K | 0.05% | +5,389 | New | +$808K |
|
248
Gilead Sciences
GILD
$140B
| $807K | 0.05% | 8,220 -8,899 | -52% | -$874K |
|
249
CoStar Group
CSGP
$37.9B
| $677K | 0.04% | +3,422 | New | +$677K |
|
|
MXPT
250
DELISTED
MaxPoint Interactive, Inc.
MXPT
| $671K | 0.04% | +70,000 | New | +$671K |
|